The same authors have gone on to use osteopontin protein expression in a multimarker assay including two other markers not present on our DASL cancer panel (NCOA3, a member of the steroid receptor coactivator 1 family and RGS1, a GTPase-activating protein) and found the multimarker index to be the most significant factor in predicting RFS (Kashani-Sabet et al, 2009). This evidence concerns the gene NCOA1 and cancer.